4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-020189
Chief of Research sold 3,184 shares at an average $4.11 ($13,085)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cox Bryan F. Chief of Research | 2026-03-11 | Sale | −1,138 | $4.13 | $4,700 | 165,461 | D |
| Cox Bryan F. Chief of Research | 2026-03-12 | Sale | −1,467 | $4.09 | $6,000 | 163,994 | D |
| Cox Bryan F. Chief of Research | 2026-03-16 | Sale | −579 | $4.12 | $2,385 | 163,415 | D |
| Open-market sales · 3,184 sh · avg $4.11 · $13,085 | |||||||
Loading xslF345X06/wk-form4_1774038346.xml…